Published in Women's Health Weekly, December 9th, 2004
D. Somjen, at the Tel Aviv Sourasky Medical Center, Israel, and colleagues wrote, "In premenopausal human bone cells, the response to estradiol-17beta and glabridin (at higher concentration) was higher than in postmenopausal cells; whereas, glabrene (at higher concentration) was more effective in postmenopausal cells.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly